Showing 8,181 - 8,200 results of 8,567 for search 'Pangda~', query time: 1.50s Refine Results
  1. 8181
  2. 8182
  3. 8183
  4. 8184
  5. 8185
  6. 8186
  7. 8187

    Review of the Handbook of Accounting, Accountability and Governance edited by Garry D. Carnegie and Christopher J. Napier by Anna Szychta

    Published 2024-12-01
    “…The authors come from various countries, including the United Kingdom and Ireland, Australia and New Zealand, some Western countries of continental Europe (Finland, Germany, Italy, Portugal, and Spain), as well as Canada, the United States of America, and Saudi Arabia. …”
    Get full text
    Article
  8. 8188
  9. 8189
  10. 8190

    Examining the impact of a community-based exercise intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility and physical activity among adults living... by Kelly K O'Brien, Aileen M Davis, Soo Chan Carusone, Lisa Avery, Ada Tang, Patricia Solomon, Rachel Aubry, Mehdi Zobeiry, Ivan Ilic, Zoran Pandovski, Ahmed M Bayoumi

    Published 2021-01-01
    “…<h4>Methods</h4>We conducted a longitudinal intervention study with community-dwelling adults living with HIV in Toronto, Canada. We measured cardiopulmonary fitness (V̇O2peak (primary outcome), heart rate, blood pressure), strength (grip strength, vertical jump, back extension, push-ups, curl ups), flexibility (sit and reach test), and self-reported physical activity bimonthly across three phases. …”
    Get full text
    Article
  11. 8191
  12. 8192

    Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age by Antoni Noguera-Julian, Emma Wilhelmi, Maria Cussó, Rob Aarnoutse, Angela Colbers, Loreto Martorell, Maria Goretti López-Ramos, Joan Vinent, Rosa Farré, Dolors Soy, Sílvia Simó-Nebot, Clàudia Fortuny

    Published 2025-01-01
    “…<b>Methods</b>: We aimed to characterize the pharmacokinetics of a licensed INH suspension (10 mg/mL, Pharmascience Inc., Montreal, QC, Canada) in children receiving INH daily at 10 mg/kg in a single-center, open-label, non-randomized, phase IIa clinical trial (EudraCT Number: 2016-002000-31) in Barcelona (Spain). …”
    Get full text
    Article
  13. 8193

    Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care. by Tea Rosic, Glenda Babe, Myanca Rodrigues, Brittany B Dennis, Richard Perez, Claire de Oliveira, Andrew Worster, Lehana Thabane, Zainab Samaan

    Published 2025-01-01
    “…<h4>Methods</h4>We linked observational cohort data collected from 3,430 individuals receiving treatment for OUD in Ontario, Canada, with health administrative records available for all individuals enrolled in Ontario's public health insurance program. …”
    Get full text
    Article
  14. 8194
  15. 8195
  16. 8196
  17. 8197
  18. 8198
  19. 8199
  20. 8200